Publications

Publications

Filter Results: (421) Arrow Down
Filter Results: (421) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 21 of 421 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 25 Oct 2016
  • First Look

October 25, 2016

New York: Springer Building a Culture of Health: A New Imperative for Business By: Quelch, John A., and Emily C. Boudreau Abstract—This ambitious volume sets out to understand how every company impacts public health and introduces a... View Details
Keywords: Sean Silverthorne
  • 27 May 2009
  • First Look

First Look: May 27, 2009

Case 509-048 The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical... View Details
Keywords: Martha Lagace
  • 24 May 2011
  • First Look

First Look: May 24

4,646 public companies in many industries, headquartered in 46 countries during 2005-2008, when environmental disclosure increased among many global corporations. Controlling for a host of organizational, industry, and national... View Details
Keywords: Sean Silverthorne
  • 02 Mar 2010
  • First Look

First Look: March 2

innovation in a wide range of other industries, including pharmaceuticals and biotechnology, IT and telecommunications, defense, chemicals, and agriculture. We believe that there are valuable lessons in this research for the energy... View Details
Keywords: Martha Lagace
  • 12 Jan 2016
  • First Look

January 12, 2016

November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing drug surveillance is the process of monitoring the adverse... View Details
Keywords: Carmen Nobel
  • 05 Aug 2008
  • First Look

First Look: August 5, 2008

/b01/en/common/item_detail.jhtml?id=808167 The Coartem Challenge (A) Harvard Business School Case 706-037 In November 2005, Novartis, a major global pharmaceutical firm, is reviewing its Coartem program, an ambitious attempt to deliver... View Details
Keywords: Martha Lagace
  • 03 Mar 2009
  • First Look

First Look: March 3, 2009

challenges involved in developing and executing the new service model and offers students opportunities to discuss the evolving challenges the company faces looking forward. Purchase this case:... View Details
Keywords: Martha Lagace
  • 28 May 2008
  • First Look

First Look: May 28, 2008

goals? Purchase the case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308030 Can PACIV (Puerto Rico) Serve European Customers? Harvard Business School Case 808-099 Jorge Rodriguez-Gonzalez, PACIV's (Puerto Rico) founding CEO, is considering expanding... View Details
Keywords: Martha Lagace
  • 12 Jan 2010
  • First Look

First Look: Jan. 12

and illustrates, via a detailed description of the successful strategic alliance between Solvay Pharmaceuticals Inc. and Quintiles company how the creation of a strategy map and Balanced Scorecard helps... View Details
Keywords: Martha Lagace
  • 24 Apr 2018
  • First Look

First Look at New Research and Ideas, April 24, 2018

Bird, Yanhua Z., Jodi L. Short, and Michael W. Toffel Abstract—Exploitive working conditions have spurred companies to pressure their suppliers to adopt labor codes of conduct and to conform their labor practices to the standards set... View Details
Keywords: Sean Silverthorne
  • 24 Feb 2009
  • First Look

First Look: February 24, 2009

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:... View Details
Keywords: Martha Lagace
  • 29 Jan 2013
  • First Look

First Look: Jan. 29

facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals... View Details
Keywords: Sean Silverthorne
  • 18 Dec 2012
  • First Look

First Look: December 18

pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access... View Details
Keywords: Carmen Nobel

Are you looking for?

→Search All HBS Web